Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7478 p549
17 November 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Government defends the electronic patient record against criticism from MPs

The Government has defended the much-criticised NHS Care Records Service in its response to a House of Commons Health Committee report on the electronic patient record (PJ, 22 September 2007, p320) by saying that a number of the committee's suggestions are already being implemented.

The Health Committee report advised that the summary care record (SCR) should include a single standard front screen to display key health information that is vital for emergency care.

In its response, the Government confirms that this will be the case and that information on this page will include details of prescriptions issued in the previous six months and repeat prescriptions that are not more than six months beyond their review date, known allergies, and known adverse reactions to medicines and other substances.

The Government accepts many recommendations made by the Health Committee. For example, it agrees in principle that patients should be able to view an audit trail to see who has accessed their SCR on the secure NHS web service HealthSpace.

Consideration will be given to how best to achieve this. It also agreed to trial the use of HealthSpace for patients to record their own measurements of key health information.

The Government highlights that the SCR early adopter programme will provide experience and learning that will guide the future development of the SCR.

The response is available on the Department of Health website

EPS system approval NHS Connecting for Health has authorised the national roll out of Capa, Pharmacy Plus’s electronic prescription service release 1-compliant system. Now 11 systems have been approved for national roll-out, including four in-house systems and seven commercially available systems.

Details can be found online

Back to Top


©The Pharmaceutical Journal